Humana 2015 Annual Report Download - page 160

Download and view the complete annual report

Please find page 160 of the 2015 Humana annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 166

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166

152
Humana Inc.
SCHEDULE I—PARENT COMPANY FINANCIAL INFORMATION
CONDENSED STATEMENTS OF CASH FLOWS
For the year ended December 31,
2015 2014 2013
(in millions)
Net cash provided by operating activities $ 953 $ 1,499 $ 1,554
Cash flows from investing activities:
Proceeds from sale of business 1,055 — —
Acquisitions — — —
Capital contributions to operating subsidiaries (833)(442)(521)
Purchases of investment securities (507)(629)(320)
Proceeds from sale of investment securities 18 606 35
Maturities of investment securities 108 149 104
Purchases of property and equipment, net (378)(380)(223)
Net cash used in investing activities (537)(696)(925)
Cash flows from financing activities:
Proceeds from issuance of senior notes, net — 1,733 —
Proceeds from issuance of commercial paper, net 298 — —
Repayment of long-term debt — (500)—
Change in book overdraft (16)(5)7
Common stock repurchases (385)(872)(531)
Dividends paid (172)(172)(168)
Tax benefit from stock-based compensation 15 12 8
Proceeds from stock option exercises and other 22 51 65
Net cash (used in) provided by financing activities (238) 247 (619)
Increase in cash and cash equivalents 178 1,050 10
Cash and cash equivalents at beginning of year 1,211 161 151
Cash and cash equivalents at end of year $ 1,389 $ 1,211 $ 161
See accompanying notes to the parent company financial statements.